We are live on ! Find out more
PA

Pinnacle Associates Portfolio holdings

AUM $7.78B
1-Year Est. Return 45.07%
This Fund
S&P 500
This Quarter Est. Return
+0.19%
1 Year Est. Return
+45.07%
3 Year Est. Return
+102.47%
5 Year Est. Return
+115.95%
10 Year Est. Return
+586.2%
AUM
$5.1B
AUM Growth
-$102M
Cap. Flow
-$32.6M
Cap. Flow %
-0.64%
Top 10 Hldgs %
18.28%
Holding
726
New
46
Increased
201
Reduced
386
Closed
48

Sector Composition

Rank Sector Weight
1 Technology 21.16%
2 Healthcare 14%
3 Communication Services 13.38%
4 Industrials 10.33%
5 Financials 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRKS icon
76
United Parks & Resorts
PRKS
$2.15B
$18.8M 0.37%
1,265,565
+1,188,745
+1,547% +$17.5M
VIAV icon
77
Viavi Solutions
VIAV
$8.65B
$18.6M 0.36%
1,914,427
-84,530
-4% -$805K
PG icon
78
Procter & Gamble
PG
$335B
$18.5M 0.36%
233,328
-5,202
-2% -$434K
PNC icon
79
PNC Financial Services
PNC
$99.2B
$18.2M 0.36%
120,422
-2,753
-2% -$427K
FNSR
80
DELISTED
Finisar Corp
FNSR
$18M 0.35%
1,136,235
-62,580
-5% -$1.18M
IVV icon
81
iShares Core S&P 500 ETF
IVV
$872B
$17.4M 0.34%
65,504
+5,844
+10% +$1.61M
PARA
82
DELISTED
Paramount Global Class B
PARA
$16.9M 0.33%
329,642
-30,113
-8% -$1.65M
VZ icon
83
Verizon
VZ
$193B
$16.7M 0.33%
349,714
+14,290
+4% +$718K
XOM icon
84
ExxonMobil
XOM
$651B
$16.6M 0.33%
223,026
-29,520
-12% -$2.36M
ETN icon
85
Eaton
ETN
$150B
$16.6M 0.32%
207,492
-9,545
-4% -$783K
ALDR
86
DELISTED
Alder Biopharmaceuticals
ALDR
$16.5M 0.32%
1,300,810
-47,820
-4% -$692K
AGN
87
DELISTED
Allergan plc
AGN
$16.1M 0.32%
95,508
+9,463
+11% +$1.59M
VEA icon
88
Vanguard FTSE Developed Markets ETF
VEA
$230B
$15.9M 0.31%
360,438
-566
-0.2% -$25.7K
SLB icon
89
SLB Ltd
SLB
$72.6B
$15.8M 0.31%
244,514
+6,803
+3% +$475K
LGF.B
90
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$15.7M 0.31%
653,980
-30,306
-4% -$870K
PGNX
91
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$15.7M 0.31%
2,101,668
-111,450
-5% -$741K
ONCE
92
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$15.6M 0.31%
+234,430
New +$13.5M
BMY icon
93
Bristol-Myers Squibb
BMY
$132B
$15.5M 0.3%
244,373
+610
+0.3% +$39.2K
IBM icon
94
IBM
IBM
$209B
$15.3M 0.3%
104,365
+7,291
+8% +$1.1M
SSP icon
95
E.W. Scripps
SSP
$259M
$15M 0.29%
1,248,364
-38,245
-3% -$558K
ABBV icon
96
AbbVie
ABBV
$455B
$14.9M 0.29%
157,746
+2,581
+2% +$284K
PTLA
97
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$13.9M 0.27%
425,616
-19,060
-4% -$836K
META icon
98
Meta Platforms (Facebook)
META
$1.37T
$13.8M 0.27%
86,404
+8,213
+11% +$1.47M
DAL icon
99
Delta Air Lines
DAL
$58.3B
$13.7M 0.27%
249,647
+21,430
+9% +$1.18M
RTX icon
100
RTX Corp
RTX
$289B
$13.5M 0.26%
170,164
+17,329
+11% +$1.43M

Similar funds

Pinnacle Associates's Q1 2018 Portfolio in Review

As of Q1 2018, Pinnacle Associates held 726 positions worth $5.1B, down 2% from $5.2B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Pinnacle Associates's Q1 2018 filing shows 46 new, 201 increased, 386 reduced and 48 closed positions. Its largest new stake was Advanced Energy: 358,420 shares worth $22.9M. The largest sale was State Street SPDR Bloomberg Convertible Securities ETF, an estimated $9.14M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Communication Services.

  • Pinnacle Associates's largest Q1 2018 buy was Advanced Energy: 358,420 shares worth $22.9M.
  • Pinnacle Associates added most to United Parks & Resorts in Q1 2018, an estimated $17.5M increase.
  • Pinnacle Associates's biggest Q1 2018 reduction was State Street SPDR Bloomberg Convertible Securities ETF, cutting an estimated $9.14M.
  • Pinnacle Associates fully exited Broadcom in Q1 2018, selling an estimated $3.24M.
  • Pinnacle Associates's ten largest holdings make up 18% of its $5.1B portfolio in Q1 2018.
  • Pinnacle Associates opened 46 new positions and closed 48 in Q1 2018.
  • Pinnacle Associates's portfolio value fell 2% quarter-over-quarter to $5.1B.

Based on Pinnacle Associates's 13F filing for Q1 2018, filed 11 May 2018.